Shenzhen Hepalink Ph Dividend yield

Shenzhen Hepalink Ph is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Shenzhen Hepalink Ph is a company from China, and his stocks are publicly traded.

Shenzhen Hepalink Ph stock dividend

Shenzhen Hepalink Ph paid a total dividend of 24 million HKD last year, for a market value of 902 millions (Market Cap 764 millions). Shenzhen Hepalink Ph dividend per share is 0.11 HKD, and his stock market price 4.10 HKD.

According to the chart below, where dividend yield is displayed, Shenzhen Hepalink Ph has a dividend yield of 2.62%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare Shenzhen Hepalink Ph stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the high China dividend stocks list.

Shenzhen Hepalink Ph Dividend Payout

About the ability of Shenzhen Hepalink Ph to maintain his current dividend of HKD 0.11 per share, an amount that accounts for 2.62%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Shenzhen Hepalink Ph payout on ernings is currently 2.95%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that Shenzhen Hepalink Phcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Shenzhen Hepalink Ph is HKD -4.56 per share, which is lower than the dividend per share paid by the company of HKD 0.11, so the company does not generate enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Shenzhen Hepalink Ph, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Shenzhen Hepalink Ph Dividend History

Below you will find a table with the historical evolution of Shenzhen Hepalink Ph's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	2.62%	0.11	2.95%	220
2022	0.72%	0.04	2.70%	220

*In millions

Shenzhen Hepalink Ph Stock performance

Finally, last moth Shenzhen Hepalink Ph showed a return of -4.70% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -35.80% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.